Guardant Health (NASDAQ:GH) reported quarterly earnings results on February 19, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.50, beating the consensus estimate of $-0.61 by $0.11 per share. Revenue came in at $281.3M, beating the estimate of $275.4M.
Guardant Health's stock moved following the earnings release. The stock currently trades at $110.05 with a market capitalization of $12.6B.